- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04665817
Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study (CAREER)
Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Xinkai Qu, MD,PhD
- Phone Number: +86 13916320399
- Email: qxkchest@126.com
Study Contact Backup
- Name: Tingwen Weng, MD
- Phone Number: +86 13917769721
- Email: wengtingwen@alu.fudan.edu.cn
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200040
- Recruiting
- Xinkai Qu
-
Contact:
- Xinkai Qu, MD,PhD
- Phone Number: +86 13916320399
- Email: qxkchest@126.com
-
Contact:
- Tingwen Weng, MD
- Phone Number: +86 13917769721
- Email: wengtingwen@alu.fudan.edu.cn
-
Principal Investigator:
- Xinkai Qu, MD,PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Coronary CT angiography indicates that >= 1 stenosis with percent diameter stenosis between 30%-90% in a vessel >= 2mm.
- The invasive coronary angiography should be less than 30 days after the coronary CT angiography.
Exclusion Criteria:
- The target lesion has received coronary stent implantation or coronary artery bypass graft.
- Target lesion involves myocardial bridge.
- Severe heart failure (NYHA ≥III).
- Renal function is seriously damaged (eGFR<30 ml/min/1.73m2).
- Those who are contraindicated to use contrast agents, beta blockers, nitrates or adenosine drugs.
- Acute myocardial infarction within 1 month.
- The image quality of CTA or coronary angiography cannot be assessed.
- Any factors that affect the image quality of coronary CTA and coronary angiography, such as frequent premature contractions, atrial fibrillation, etc.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic performance of CT-QFR
Time Frame: 1.5 year
|
Diagnostic accuracy of on-site CT-QFR in identifying physiologically significant coronary artery stenosis, using FFR as the reference standard. Presence of hemodynamically-significant coronary artery stenosis : FFR <= 0.80. |
1.5 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparision between CT-QFR and QFR
Time Frame: 1.5 year
|
Use FFR as a reference standard to validate the non-inferiority of CT-QFR compared with QFR in the vessels without extensively calcified lesions defined by the combination of a cross-sectional calcium arc >90° and a thickness >1.5 mm.
For CT-QFR, QFR and FFR evaluations, vessels with <=0.80 are regarded as having hemodynamically significant CAD.
|
1.5 year
|
|
Other common measures of diagnostic performance of CT-QFR
Time Frame: 1.5 year
|
Other common measures of diagnostic performance of CT-QFR, including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) at the patient level compared with FFR as the reference standard. Presence of hemodynamically-significant coronary artery stenosis : FFR <= 0.80. |
1.5 year
|
|
Correlation between CT-QFR and FFR
Time Frame: 1.5 year
|
Pearson correlation or spearman's correlation will be used to quantify the correlations between CT-QFR and FFR. Agreements between CT-QFR and FFR will be assessed by Bland-Altman plot. The correlation coefficient r=0-0.2 represents very weak or no correlation. 0.2-0.4 represents weak correlation. 0.4-0.6 represents moderate correlation. 0.6-0.8 represents strong correlation. 0.8-1.0 represents very strong correlation. |
1.5 year
|
|
The comparison between CT-QFR, CCTA-derived percent diameter stenosis (CTA-DS%) and QCA-derived DS%
Time Frame: 1.5 year
|
The comparison of the discrimination ability between CT-QFR, CCTA-derived percent diameter stenosis (CTA-DS%), and QCA-derived DS% for identifying physiologically significant stenosis with FFR as the reference standard. Presence of hemodynamically-significant coronary artery stenosis : FFR <= 0.80. |
1.5 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xinkai Qu, MD,PhD, Huadong Hospital, Department of Cardiology
- Principal Investigator: Tingwen Weng, MD, Huadong Hospital, Department of Cardiology
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Huadong Hospital
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
Clinical Trials on CT-QFR
-
China National Center for Cardiovascular DiseasesThe First Affiliated Hospital with Nanjing Medical University; Ruijin Hospital and other collaboratorsNot yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruitingCoronary Artery Disease | Angina, StableChina
-
Contilia Clinical Research InstituteUnknownCoronary Artery Disease | Fractional Flow Reserve, MyocardialGermany
-
Seoul National University HospitalUlsan University Hospital; Severance Hospital; Keimyung University Dongsan Medical... and other collaboratorsCompleted
-
Samsung Medical CenterSeoul National University Hospital; Inje University; Chosun University Hospital; Dongsan Medical CenterCompletedIschemic Heart DiseaseKorea, Republic of
-
Aarhus University Hospital SkejbyCompletedCoronary Artery DiseaseUnited Kingdom, Japan, Denmark, France, Germany, Italy, Netherlands
-
Seoul St. Mary's HospitalNational Research Foundation of Korea; Seoul Saint Mary's Hospital; Incheon Saint... and other collaboratorsCompleted
-
Shaanxi Provincial People's HospitalEnrolling by invitationCoronary Atherosclerosis of Native Coronary ArteryChina
-
Niels Ramsing HolmCompleted
-
Azienda Ospedaliera Sant'Anna e San SebastianoUnknownCoronary Artery Disease | Percutaneous Coronary Intervention | STEMI - ST Elevation Myocardial InfarctionItaly